Violation Tracker Parent Company Summary

Parent Company Name: 
GlaxoSmithKline
Ownership Structure: 
publicly traded (ticker symbol GSK)
Headquartered in: 
Britain
Industry: 
pharmaceuticals
Penalty total since 2000: 
$3,921,333,673
Number of records: 
9
Top 10 Primary Offense TypesPenalty TotalNumber of Records
off-label or unapproved promotion of medical products$3,000,000,0001
drug or medical equipment safety violation$750,000,0001
False Claims Act$150,000,0001
kickbacks and bribery$20,000,0001
environmental violation$980,9004
wage and hour violation$352,7731
Notes: 

Parent-subsidiary linkages are based on relationships current as of the latest revision listed in the Update Log, which may vary from what was the case when a violation occurred. The penalty dollar total above may be adjusted to account for the fact that the list of entries below may include both agency records and settlement announcements for the same case; or else a penalty covering multiple locations may be listed in the individual records for each of the facilities. Duplicate penalty amounts are marked with an asterisk in the list below.

Associated Names: 

BLOCK DRUG; GLAXOSMITHKLINE; GLAXOSMITHKLINE PLC; GLAXOSMITHKLINE VACCINES; SB PHARMCO PUERTO RICO

Links: 

For an overview of this company's accountability track record, read its Corporate Rap Sheet here.

For more details on misconduct by this company, see its entry in the Project On Government Oversight's Federal Contractor Misconduct Database.

For a summary of this company's federal contracts, see its page on Fedspending.

Subsidy Tracker data on financial assistance to this company by federal, state and local government agencies can be found here.


Individual Penalty Records:

Download results as CSV or XML
Company Primary Offense Type Year Agency Penalty Amountsort icon
GlaxoSmithKline LLC off-label or unapproved promotion of medical products 2012 FDA $3,000,000,000
SB Pharmco Puerto Rico Inc. drug or medical equipment safety violation 2010 FDA $750,000,000
GlaxoSmithKline False Claims Act 2005 DOJ_CIVIL $150,000,000
GlaxoSmithKline plc kickbacks and bribery 2016 SEC $20,000,000
Block Drug Company Incorporated wage and hour violation 2011 WHD $352,773
GlaxoSmithKline LLC environmental violation 2014 EPA $317,550
GLAXOSMITHKLINE, LLC environmental violation 2014 EPA $317,550
GlaxoSmithKline Vaccines environmental violation 2014 EPA $172,900
GLAXOSMITHKLINE VACCINES environmental violation 2014 EPA $172,900
Download results as CSV or XML